Login
$ROIV
$39.11 +$0.50 (1.3%) After hours

$ROIV SEC Filings

Filed On Filing
13 Nov 2026 144/A
13 Nov 2026 144/A
12 Nov 2026 Form 4: Torti Frank, President and Vant Chair

Disposed of 392,052 shares (Other Transaction) ($16M) · Disposed of 392,048 shares (Other Transaction) ($16.4M) · Disposed of 392,043 shares (Other Transaction) ($15.9M) · 1 more

12 Nov 2026 Form 4: Gline Matthew, Director

Disposed of 58,331 shares (Other Transaction) ($2.38M) · Disposed of 48,988 shares (Other Transaction) ($2.05M) · Disposed of 48,988 shares (Other Transaction) ($1.98M) · 1 more

12 Nov 2026 Form 4: Sukhatme Mayukh, Director

Disposed of 59,034 shares (Other Transaction) ($2.41M) · Disposed of 53,205 shares (Other Transaction) ($2.22M) · Disposed of 53,205 shares (Other Transaction) ($2.15M) · 1 more

12 Nov 2026 Form 4: Pulik Richard, CFO

Received 125,000 shares by exercise or conversion ($481K) · Sold 125,000 shares ($5.15M) · Received 127,365 shares by exercise or conversion ($490K) · 1 more

12 Nov 2026 Form 4: Venker Eric, President & Immunovant CEO

Sold 187,943 shares ($7.62M)

12 Nov 2026 144
10 Nov 2026 144/A
10 Nov 2026 144/A
10 Nov 2026 144/A
10 Nov 2026 144
10 Nov 2026 144
10 Nov 2026 144
10 Nov 2026 144
10 Nov 2026 144
09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

BASEL, Switzerland and LONDON and NEW YORK, November 9, 2026 – Roivant (Nasdaq: ROIV) today reported its financial results for the second quarter ended September 30, 2026, and provided a business update.

05 Nov 2026 Form 4: Venker Eric, President & Immunovant CEO

Sold 200,000 shares ($7.26M)

05 Nov 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support